CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
Authors:
- Kerry AtkinsonKAKerry Atkinson
- James BiggsJBJames Biggs
- Paul DarvenizaPDPaul Darveniza
- John BolandJBJohn Boland
- Alan ConcannonACAlan Concannon
- Anthony DoddsADAnthony Dodds
- 1 July 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 38 (1) , 34-36
Abstract
Five of 64 recipients of HLA-identical sibling marrow allografts who were given cyclosporin (CSP) to minimize graft-versus-host disease posttransplant had a serious neurological illness thought to be due to CSP. Characteristic clinical features included a motor spinal cord syndrome, a cerebellar-like syndrome, and mental confusion. All five recovered when the CSP dose was reduced or the drug was stopped.Keywords
This publication has 10 references indexed in Scilit:
- Tissue distribution and toxicity of cyclosporin a in the mousePathology, 1984
- Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromesBritish Journal of Haematology, 1983
- MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIAThe Lancet, 1983
- Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantationBritish Journal of Haematology, 1983
- Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.BMJ, 1982
- USE OF CYCLOSPORIN A IN ALLOGENEIC BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIATransplantation, 1982
- Heart-Lung TransplantationNew England Journal of Medicine, 1982
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Encephalopathy following bone marrow transplantation1977